glp-1/gip receptor agonists New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight LY3437943, a novel triple glucagon,

Other plant-derived bioactive compounds are continually being explored for their potential to target the GLP-1 pathway, as highlighted by Liu et al

Retatrutide versus semaglutide versus tirzepatide: understanding why people search online The surge in online retatrutide searches is driven by clinical data that positions it as the most potent weight loss peptide in development

Advance in Peptide-based Drug Development: Delivery Platforms, Therapeutics and Vaccines

Nausea can potentially be prevented by making dietary changes, such as eating smaller and more frequent meals, eating slowly, avoiding food with high fat content, and drinking clear or ice cold drinks

Unger then demonstrated in 1968 that intraduodenal, but not intravenous, glucose administration increases circulating glucagon-like immunoreactivity [27], implying that the intestine secretes this glucagon-like material